RIGL · Forms 3, 4, 5

Insider trades at RIGEL PHARMACEUTICALS INC

No open-market insider buys or sells at RIGEL PHARMACEUTICALS INC in the last 90 days; 4 filings reported awards, option exercises, tax withholding or new insiders.

Every Form 3, 4 and 5 filed for RIGEL PHARMACEUTICALS INC (RIGL) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.

Insider trades in the last 90 days

DateInsiderRoleTransactionSharesPriceValueFiling
Dean L SchornoEVP & Chief Financial OfficerOption exercise694$12.70$9KForm 4
Dean L SchornoEVP & Chief Financial OfficerOption exercise620$18.70$12KForm 4
Dean L SchornoEVP & Chief Financial OfficerOption exercise2,000$24.20$48KForm 4
Dean L SchornoEVP & Chief Financial OfficerOption exercise1,286$24.20$31KForm 4
Dean L SchornoEVP & Chief Financial OfficerTax withholding928$47.50$44KForm 4
David A SantosEVP, Chief Commercial OfficerTax withholding874$47.50$42KForm 4
Raul R RodriguezCEO, PresidentTax withholding2,424$47.50$115KForm 4
Raymond J. FureyEVP, GC, CCO & Corp SecTax withholding877$47.50$42KForm 4

Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.